TY - JOUR
T1 - Surgical methods and clinical results of subfascial endoscopic perforator surgery in Japan
AU - Japanese SEPS study group
AU - Kusagawa, Hitoshi
AU - Haruta, Naoki
AU - Shinhara, Ryo
AU - Hoshino, Yuji
AU - Tabuchi, Atsushi
AU - Sugawara, Hiromitsu
AU - Shinozaki, Koji
AU - Matsuzaki, Kenji
AU - Nagata, Hidetoshi
AU - Niihara, Hiroyuki
AU - Kohno, Kunie
AU - Takeda, Ryoji
N1 - Publisher Copyright:
© The Author(s) 2018.
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Objectives: To clarify the surgical methods and the clinical results of subfascial endoscopic perforator surgery in Japan. Methods: This study included 1287 limbs of 1091 patients who underwent subfascial endoscopic perforator surgery in 14 hospitals. Simultaneous saphenous vein treatment was performed in 1079 limbs (83.8%), and 118 limbs (9.2%) had deep venous lesions. The venous clinical severity score was calculated before and 6 to 12 months after surgery. The ulcer healing rate and ulcer recurrence rate were calculated cumulatively. Results: Preoperative venous clinical severity score was significantly decreased from 10.0 ± 6.6 to 3.1 ± 3.4 (P <.0001) postoperatively. The primary ulcer healing rate was 96.2% (332/345 C6 limbs) at an average follow-up of 47.7 months, and the ulcer recurrence rate was 12.0% (49/393 C5, C6 limbs) at the average follow-up of 46.0 months after the ulcer healed. Conclusion: These results indicate that subfascial endoscopic perforator surgery is an alternative to improve the long-lasting disease severity and/or clinical outcome.
AB - Objectives: To clarify the surgical methods and the clinical results of subfascial endoscopic perforator surgery in Japan. Methods: This study included 1287 limbs of 1091 patients who underwent subfascial endoscopic perforator surgery in 14 hospitals. Simultaneous saphenous vein treatment was performed in 1079 limbs (83.8%), and 118 limbs (9.2%) had deep venous lesions. The venous clinical severity score was calculated before and 6 to 12 months after surgery. The ulcer healing rate and ulcer recurrence rate were calculated cumulatively. Results: Preoperative venous clinical severity score was significantly decreased from 10.0 ± 6.6 to 3.1 ± 3.4 (P <.0001) postoperatively. The primary ulcer healing rate was 96.2% (332/345 C6 limbs) at an average follow-up of 47.7 months, and the ulcer recurrence rate was 12.0% (49/393 C5, C6 limbs) at the average follow-up of 46.0 months after the ulcer healed. Conclusion: These results indicate that subfascial endoscopic perforator surgery is an alternative to improve the long-lasting disease severity and/or clinical outcome.
UR - http://www.scopus.com/inward/record.url?scp=85041925867&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041925867&partnerID=8YFLogxK
U2 - 10.1177/0268355517750523
DO - 10.1177/0268355517750523
M3 - Article
C2 - 29301462
AN - SCOPUS:85041925867
SN - 0268-3555
VL - 33
SP - 678
EP - 686
JO - Phlebology
JF - Phlebology
IS - 10
ER -